Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as well as managing the entire company’s U.S. sales and service center. Mazzo comes from a 3-year run as president and CEO at AcuFocus, where […]
Carl Zeiss Meditec
FDA reverses stance on reporting requirement | Regulatory news for the week of October 20, 2014
Abbott inks co-distribution deal with Carl Zeiss Meditec
China fines J&J and other contact lens makers for anti-trust violations
Chinese regulators slapped a string of contact lens and eyeglass makers with more than $3 million (19 million yuan) in fines after accusing them of violating the country’s anti-trust laws.
Carl Zeiss expands lens portfolio with $70M Aaren Scientific buy
Optical lenses maker Carl Zeiss Meditec (ETR:AFX) paid $70 million to acquire 100% of the assets of intraocular lens manufacturer Aaren Scientific, the companies announced this week.
Kensey Nash recoups on Angio-Seal settlement with St. Jude | Legal Roundup
